Subtype-selective antagonism of NMDA receptors by nylidrin

Author： Whittemore E.R.   Ilyin V.I.   Konkoy C.S.   Woodward R.M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.337, Iss.2, 1997-10, pp. : 197-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004

By McCauley John A  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 389-407

Informa Healthcare

Access to resources Recommend Favorite

Heterogeneity of GABAA Receptors: Revived Interest in the Development of Subtype-selective Drugs

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 3, 2005-09 ,pp. : 217-242

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of NR2B Subtype-Selective NMDA Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 7, 2006-04 ,pp. : 697-709

Bentham Science Publishers

Access to resources Recommend Favorite

The subtype-selective 2 -adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT 1A receptors in the rat brain

By Meana J.J.   Callado L.F.   Pazos A.   Grijalba B.   Garcia-Sevilla J.A.  

European Journal of Pharmacology, Vol. 312, Iss. 3, 1996-10 ,pp. : 385-388

Elsevier

Access to resources Recommend Favorite

Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors

By Pittaluga A.   Pattarini R.   Raiteri M.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 203-209

Elsevier

Access to resources Recommend Favorite